On Monday, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)’s shares inclined 0.50% to $4.06.
Arena Pharmaceuticals, Inc. (ARNA) declared that it will host a conference call and webcast at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) on Wednesday, August 5, 2015, to talk about second quarter 2015 financial results and provide a corporate update. Arena will release its financial results after the NASDAQ Global Select Market closes that day.
Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight administration in adults. It is also developing a portfolio of programs in various therapeutic areas, counting cardiovascular, central nervous system, and metabolic diseases. Its products under development comprise Ralinepag, an agonist of the prostacyclin receptor intended for the treatment of vascular diseases, counting potentially pulmonary arterial hypertension that is in Phase II clinical trials.
Banco Bilbao Vizcaya Argentaria SA (ADR) (NYSE:BBVA)’s shares gained 0.10% to $10.13.
BBVA Compass declared that information security veteran Caleb Merriman has been named its new chief security officer.
Merriman joins the bank from BlueCross BlueShield of Tennessee, where he served as the chief information security officer since 2012, responsible for the company’s security programs. He has more than 20 years of experience, formerly holding senior information security positions in a broad range of industries, such as health insurance, retail, financial services and medical technology. He will be based in Birmingham.
Banco Bilbao Vizcaya Argentaria, S.A. engages in the retail banking, wholesale banking, asset administration, and private banking businesses primarily in Spain, Eurasia, Mexico, South America, and the United States. It offers deposit products, counting personal accounts, housing accounts, savings accounts, deposit accounts, etc.; and loan products, such as personal loans, mortgages, etc.; credit cards; investment products comprising mutual funds, warrants, and pension plans; and telephone and on-line banking services, in addition to ATMs for individual customers.
At the end of Monday s trade, PTC Inc (NASDAQ:PTC)‘s shares surged 0.63% to $36.58.
PTC ( PTC) stated revenue for the third quarter of FY’15 of $303.1 million. Net income was $17.4 million or $0.15 per share, which compares to revenue of $336.6 million and net income of $38.0 million or $0.32 per share in the third quarter FY’14.
Third quarter FY’15 non-GAAP revenue was $303.9 million. Non-GAAP net income was $61.7 million or $0.53 per share, which compares to non-GAAP net income of $63.7 million or $0.53 per share, in the third quarter FY’14.
PTC Inc. develops, markets, and supports software products and solutions in the areas of computer-aided design (CAD), product lifecycle administration (PLM), application lifecycle administration (ALM), service lifecycle administration (SLM), and Internet of things (IoT) worldwide.
HealthSouth Corp (NYSE:HLS), ended its Monday’s trading session with 1.33% gain, and closed at $46.31.
HealthSouth Corporation (HLS), one of the nation’s largest providers of post-acute healthcare services, offering both facility-based and home-based post-acute services, stated its results of operations for the second quarter ended June 30, 2015.
Second Quarter Merged Results
- The Company’s merged net operating revenues raised by $160.0 million, or 26.5%, in the second quarter of 2015 contrast to the second quarter of 2014. About $114 million of this enhance resulted from the Company’s acquisition of Encompass Home Health and Hospice (“Encompass”) on December 31, 2014. The remainder of the enhance predominantly came from the Company’s inpatient rehabilitation hospitals. Net operating revenues from the Company’s hospitals were 8.6% higher for the second quarter of 2015 contrast to the same quarter of 2014.
- Income from ongoing operations attributable to HealthSouth per diluted share for the second quarter of 2015 was $0.47 per share contrast to $0.81 per share for the second quarter of 2014. Earnings per share for the second quarter of 2014 benefited by $0.26 per share due to the Company’s enhance in ownership and consolidation of Fairlawn Rehabilitation Hospital (“Fairlawn”) in Worcester, Massachusetts effective June 1, 2014, counting the associated tax benefits of the transaction. Earnings per share for the second quarter of 2015 comprised of an $18.8 million, or $0.11 per share, loss on early extinguishment of debt associated with the Company’s redemption of its 8.125% Senior Notes due 2020 (the “2020 Notes”), as talk abouted below. The Company’s earnings per share in the second quarter of 2015 also reflected raised depreciation and amortization resulting from the Company’s capital expenditures and development activities throughout 2014 and the first half of 2015, in addition to higher interest expense due to the debt used to fund the acquisition of Encompass on December 31, 2014.
- Cash flows offered by operating activities were $204.9 million for the six months ended June 30, 2015 contrast to $235.1 million for the six months ended June 30, 2014. This decrease primarily resulted from enhances in working capital and cash interest expense, in addition to transaction costs incurred to date in connection with the Company’s pending acquisition of Reliant Hospital Partners, LLC and associated entities (“Reliant”).
HealthSouth Corporation owns and operates inpatient rehabilitation hospitals in the United States. The company provides specialized rehabilitative treatment on an inpatient and outpatient basis. Its inpatient rehabilitation hospitals offer specialized rehabilitative care services to patients in various disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.